SoFi stock: New SEC filing flags adviser deal as investors look to Jan. 30 results

SoFi stock: New SEC filing flags adviser deal as investors look to Jan. 30 results

New York, Jan 11, 2026, 19:08 EST — Market closed.

  • SoFi revealed an adviser agreement with retired general counsel Stephen Simcock, according to an SEC filing
  • Shares closed Friday at $27.40, slipping roughly 1%
  • SoFi’s earnings report and conference call set for Jan. 30 will be the next major catalyst for investors

SoFi Technologies, Inc. announced that its former general counsel, Stephen Simcock, will remain on as an adviser until the end of 2026, per a Form 8-K filing used to report significant company updates.

The disclosure isn’t exactly a surprise, but it comes at a sensitive time. Investors are closely tracking how SoFi manages staffing, controls, and oversight following a major share sale and just before its upcoming quarterly report.

For a fintech dealing in loans, deposits, and pitched as quick on its feet, that really hits home. Slip-ups in governance or risk controls can spiral into a headline fast, even if the underlying figures are modest.

Simcock retired effective Dec. 31, 2025, the filing showed. The company said he will provide transition services from Jan. 5, 2026, through Dec. 31, 2026, for a monthly fee of $83,333.33, plus company-paid COBRA subsidies — a U.S. program that lets former employees keep health coverage for a period.

SoFi shares ended Friday at $27.40, slipping 32 cents, or 1.15%. During the session, the stock fluctuated between $27.23 and $28.38, with volume surpassing 43 million shares.

The stock has stayed close to the price set in SoFi’s recent offering, with dilution and capital deployment still under scrutiny. Investors are looking for the company to convert new equity into quicker growth while maintaining margins.

SoFi revealed in a separate 8-K filed earlier this month that underwriters exercised an option related to its public stock offering, pushing total shares sold to 57,754,660 at $27.50 each. The filing named Goldman Sachs, BofA Securities, Citigroup Global Markets, Deutsche Bank Securities, and Mizuho Securities USA as the underwriters.

Traders are focused on whether SoFi can sustain loan growth alongside deposit inflows without loosening credit standards. That’s what really moves the stock—not the legal fine print.

Consumer finance and fintech peers are following a familiar script: news on funding and credit drives the mood, with rate-sensitive stocks twitching at any unexpected moves. LendingClub and Upstart remain on some investors’ radar, despite their different business models.

The downside scenario is straightforward. Rising credit losses, higher funding costs, or any hint of additional dilution could trigger another sell-off — especially since much of the risk seems priced in already.

SoFi will unveil its fourth-quarter and full-year 2025 earnings on Friday, Jan. 30, with the report due around 7 a.m. ET, followed by a conference call at 8 a.m. ET.

Khadija Saeed

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors. Follow Khadija Saeed on Google News.

AI PORTFOLIO

Top Stock Picks

Today’s highest-ranked model selections.

#1 STRONG BUY

AerCap

NYSE: AER 95 / 100
#2 BUY

Uber

NYSE: UBER 93 / 100
#3 BUY ON WEAKNESS

Taiwan Semiconductor

NYSE: TSM 91 / 100
#4 ACCUMULATE

AIG

NYSE: AIG 88 / 100
#5 BUY THE RESET

Ferguson

NYSE: FERG 86 / 100
View full portfolio
Editorial model selection. Not personalised advice.
Commonwealth Bank of Australia stock pops as banks rebound — what to watch before CBA earnings
Previous Story

Commonwealth Bank of Australia stock pops as banks rebound — what to watch before CBA earnings

CG Oncology stock (CGON) jumps 29% on faster Phase 3 timeline — what to watch next week
Next Story

CG Oncology stock (CGON) jumps 29% on faster Phase 3 timeline — what to watch next week